Sumitomo Mitsui Trust Holdings, Inc. Crispr Therapeutics Ag Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$168 Billion
Q3 2025

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,163,675 shares of CRSP stock, worth $120 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,163,675

Previous 2,414,838 10.4%

Holding current value

$120 Million

Previous $117 Million 19.39%

% of portfolio

0.08%

Previous 0.08%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	SELL	$48.51 - $68.14 $12.2 Million - $17.1 Million	-251,163 Reduced 10.4%	2,163,675 $140 Million
Q2 2025 Jul 31, 2025	SELL	$31.27 - $48.64 $3.91 Million - $6.08 Million	-125,051 Reduced 4.92%	2,414,838 $117 Million
Q1 2025 Apr 25, 2025	SELL	$34.03 - $53.02 $7 Million - $10.9 Million	-205,787 Reduced 7.49%	2,539,889 $86.4 Million
Q4 2024 Jan 28, 2025	SELL	$38.65 - $55.15 $8.59 Million - $12.3 Million	-222,358 Reduced 7.49%	2,745,676 $108 Million
Q3 2024 Nov 05, 2024	SELL	$44.62 - $62.75 $8.19 Million - $11.5 Million	-183,480 Reduced 5.82%	2,968,034 $139 Million

Q2 2024 Jul 19, 2024	SELL	$51.17 - $68.18 $6 Million - $8 Million	-117,271 Reduced 3.59%	3,151,514 $170 Million
Q1 2024 Apr 19, 2024	SELL	$60.67 - $89.12 $6.13 Million - $9 Million	-100,977 Reduced 3.0%	3,268,785 $223 Million
Q4 2023 Jan 30, 2024	SELL	$38.62 - $72.18 $3.7 Million - $6.91 Million	-95,708 Reduced 2.76%	3,369,762 $211 Million
Q3 2023 Oct 30, 2023	SELL	$45.39 - $59.0 $3.08 Million - $4.01 Million	-67,887 Reduced 1.92%	3,465,470 $157 Million
Q2 2023 Jul 31, 2023	SELL	$43.47 - $67.77 $19.1 Million - $29.8 Million	-439,823 Reduced 11.07%	3,533,357 $198 Million
Q1 2023 Apr 27, 2023	SELL	$41.0 - $56.12 $1.37 Million - $1.87 Million	-33,296 Reduced 0.83%	3,973,180 $180 Million
Q4 2022 Jan 30, 2023	SELL	$39.19 - $65.67 $10 Million - $16.8 Million	-256,260 Reduced 6.01%	4,006,476 $163 Million
Q3 2022 Oct 21, 2022	SELL	$61.1 - $83.78 $19.6 Million - $26.9 Million	-321,362 Reduced 7.01%	4,262,736 $279 Million
Q2 2022 Jul 26, 2022	SELL	$43.23 - $73.83 $1.54 Million - $2.63 Million	-35,649 Reduced 0.77%	4,584,098 $279 Million
Q1 2022 Apr 27, 2022	BUY	$53.19 - $79.24 $246 Million - $366 Million	4,619,747 New	4,619,747 $290 Million

Others Institutions Holding CRSP

# of Institutions

547

Shares Held

67.6M

Call Options Held

3.5M

Put Options Held

3.08M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.32B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account

Sumitomo Mitsui Trust Holdings, Inc. Crispr Therapeutics Ag Transaction History